Zoetis Inc. Insider Trading

ZTS

⊜ Compare

Last 12 months

Insiders bought 886K and sold $2.54M on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

−$1.65M

3 buys · 1 sale

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

3 / 1

executives and directors

Last open-market buy

May 2026

May 13, 2026

Get an email when ZTS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 13	Frank A Damelio Director	Bought	6,650	$75.39	501K	45%	Form 4
May 13	Paul Bisaro Director	Bought	2,000	$75.88	152K	7.7%	Form 4
May 11	Michael B McCallister Director	Bought	3,000	$77.76	233K	10%	Form 4
Feb 17	Kristin C Peck Chief Executive Officer	Sold10b5-1 plan 2 parts	20,000	$127.05 average	$2.54M	16%	Form 4
Jun 3, 2025	Roxanne Lagano Executive Vice President	Sold10b5-1 plan	652	$170.00	111K	3.9%	Form 4
Mar 11, 2025	Willie M Reed Director	SoldNo plan	1,210	$166.14	201K	9.7%	Form 4
Mar 10, 2025	Roxanne Lagano Executive Vice President	Sold10b5-1 plan	326	$170.00	55K	1.9%	Form 4
Feb 19, 2025	Kristin C Peck Chief Executive Officer	Sold10b5-1 plan	382	$156.68	60K	0.4%	Form 4
Feb 11, 2025	Roxanne Lagano Executive Vice President	Sold10b5-1 plan	326	$171.18	56K	1.9%	Form 4
Nov 25, 2024	Robert J Polzer Executive Vice President	SoldNo plan	3,477	$177.46	617K	45%	Form 4

May 13
Frank A Damelio
Director · bought 6,650 at $75.39
501K
45% of stake
May 13
Paul Bisaro
Director · bought 2,000 at $75.88
152K
7.7% of stake
May 11
Michael B McCallister
Director · bought 3,000 at $77.76
233K
10% of stake
Feb 1710b5-1 plan
Kristin C Peck
Chief Executive Officer · sold 20,000 at avg $127.05
$2.54M
16% of stake
Jun 3, 202510b5-1 plan
Roxanne Lagano
Executive Vice President · sold 652 at $170.00
111K
3.9% of stake
Mar 11, 2025No plan
Willie M Reed
Director · sold 1,210 at $166.14
201K
9.7% of stake
Mar 10, 202510b5-1 plan
Roxanne Lagano
Executive Vice President · sold 326 at $170.00
55K
1.9% of stake
Feb 19, 202510b5-1 plan
Kristin C Peck
Chief Executive Officer · sold 382 at $156.68
60K
0.4% of stake
Feb 11, 202510b5-1 plan
Roxanne Lagano
Executive Vice President · sold 326 at $171.18
56K
1.9% of stake
Nov 25, 2024No plan
Robert J Polzer
Executive Vice President · sold 3,477 at $177.46
617K
45% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ZTS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ZTS

CompareIntrinsic value

IDXXIDEXX Laboratories, Inc.

$698.55+3.94%80

ELANElanco Animal Health Incorporated

$25.31+3.01%46

MRKMerck & Co., Inc.

$150.36+3.93%41

DHRDanaher Corporation

$234.93+2.09%23

Held by ETFs

ZTS is in 308 US ETFs. The largest of them, with ZTS's weight in each:

Spot a number that looks wrong? Check it in ZTS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ZTS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.